InvestorsHub Logo
Followers 21
Posts 728
Boards Moderated 0
Alias Born 11/07/2003

Re: OBE post# 6795

Friday, 12/08/2017 5:51:50 PM

Friday, December 08, 2017 5:51:50 PM

Post# of 13168
Hey Obe,

I don't have PM but I hear you and my situation is similar this year sadly.

With that said I am staying the course with ALRT. With CVS/ATETNA merger and the changing business climate in this space this product is perfectly positioned. I think that merger is disruptive and can only help a disruptive tech that fits right in with their buisness plan. Whether it is CVS/Aetna or or other similar mergers I think that pharmacy/insurer business model it just the tip of the ice burg.

I think there is a lot of value in what Sidney has developed. He is very forward thinking and saw these developments in chronic care coming years before us.

I am not done reading the filing but it is packed with information and history of the company. It also shows clearly how Sidney has been financing the company.

With so little stock available to the public it really gives this company a lot of options going forward to choose the right partner, merge, be bought ect. I have no idea how long it will take to get to the next level but the steps are being taken.

No missed commitments from the company yet. There are no revenues yet but clearly the studies prove out the benefits.

In the end market will decide what happens to ALRT. It is my opinion that the value of what has been developed has monster revenue potential for a stock at this price